American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting - Oral presentation

WANG, L. (Speaker)

Chinese Medicine - Teaching and Research Division

Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units

Description

A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low cardiovascular risk in osteogenesis imperfecta mice

Number of attendees (for events)

5000

Period	20 Sept 2019 → 23 Sept 2019
Held at	American Society for Bone and Mineral Research, United States